Despite the increasing availability of tandem mass spectrometry (MS/MS) community spectral
libraries for untargeted metabolomics over the past decade, the majority of acquired MS/…

Introduction Alzheimer's disease (AD) is accompanied by metabolic alterations both in the
periphery and the central nervous system. However, so far, a global view of AD‐associated …

… Kaddurah-Daouk … Rima F. Kaddurah-Daouk is inventor on key patents in the field of
metabolomics including applications for Alzheimer's disease. All other authors report no disclosures. …

In this study, we aimed to understand the potential role of the gut microbiome in the
development of Alzheimer's disease (AD). We took a multi-faceted approach to investigate this …

Experimental models shows that bioenergetic homeostasis changes with increasing age
based on apolipoprotein E (APOE) gene. However, such link with dementia remains unclear in …

Background Alzheimer’s disease (AD) shares risk factors with cardiovascular disease (CVD)
and dysregulated cholesterol metabolism is a mechanism common to both diseases. …

Metabolic dysregulation is a hallmark of neurodegenerative diseases, including Alzheimer’s
disease (AD) and progressive supranuclear palsy (PSP). While metabolic dysregulation is a …

Background L‐carnitine is present in the mammalian cells as free carnitine (FC) and
acylcarnitine and the adult human brain contains almost 10% of long chain acylcarnitine. …

The pathogenesis of depression is complex involving the interplay of genetic and environmental
risk factors including diet, lifestyle and the gut microbiome. Metabolomics studies may …

Background There is an important interplay between the gut microbiome and brain, commonly
known as the gut‐brain‐axis. Several studies addressed the role of the microbiome in …